MedPath

Overcoming Procrastination in Adults: a Waitlist-Controlled Trial of One-to-One Online Coaching with Trained Volunteers

Not Applicable
Active, not recruiting
Conditions
Procrastination
Registration Number
NCT06814197
Lead Sponsor
Overcome
Brief Summary

The goals of this clinical trial are to assess the feasibility and efficacy of a one-to-one, layperson-delivered, online Motivational Interviewing (MI) and Cognitive Behavioral Therapy (CBT) intervention for adults aged 18 to 64 experiencing severe procrastination but without moderate-to-severe anxiety or depression.

The main questions it aims to answer are:

* Can a layperson-delivered, online MI and CBT intervention effectively reduce procrastination compared to a waitlist control group?

* Can the intervention effectively improve self-efficacy and life satisfaction?

* Are the effects of the intervention maintained one month after completion?

Eligible participants will be randomly assigned to either the Intervention group or the Waitlist Control group, with baseline procrastination, self-efficacy, and life satisfaction measured beforehand. Participants in the intervention group will attend four weekly 60-minute online sessions delivered by trained lay coaches supervised by experienced specialists. Sessions will focus on goal-setting, identifying triggers, improving time management, and creating long-term plans to sustain progress. At the end of the intervention, 12 participants will be interviewed to share their experiences. Participants in the waitlist control group will continue their usual activities for four weeks and will receive the same intervention after completing the study assessments. This group will serve as a comparison to evaluate the effectiveness of the intervention.

Detailed Description

Procrastination is a prevalent behavioural issue affecting around 20% of adults, leading to decreased productivity, financial losses, and adverse mental health outcomes such as increased stress and reduced life satisfaction. Despite these significant effects, it is often overlooked in mental health services and under-researched as a condition requiring targeted interventions.

Cognitive Behavioural Therapy (CBT) has been the primary approach used to address procrastination, focusing on restructuring maladaptive beliefs, goal setting, and increasing task engagement. However, most existing studies focus on therapist-led interventions, making these treatments costly and less scalable. Motivational Interviewing (MI) complements CBT by addressing low self-efficacy and enhancing commitment to behavioural change through client-centred techniques such as reflective listening and eliciting "change talk". Layperson-delivered interventions, which involve non-clinicians providing structured support, have shown promise in making therapies more accessible and cost-effective.

There is limited research on scalable, lay-delivered procrastination interventions, particularly those combining CBT and MI techniques in a remote format. This study aims to address this gap by evaluating the efficacy and feasibility of a four-week online, one-to-one intervention.

The primary objectives are to:

* Measure changes in procrastination, self-efficacy, and life satisfaction.

* Assess the feasibility of delivering the intervention, focusing on recruitment, adherence, and participant satisfaction.

This is a mixed-methods, waitlist-controlled trial. Participants are randomly allocated to either an Intervention or Waitlist Control group. The intervention involves four weekly 60-minute video sessions delivered by trained lay coaches. The waitlist control group will receive the intervention after a four-week waitlist period.

Participants will be adults aged 18 to 64 with severe procrastination (Irrational Procrastination Scale \[IPS\] ≥ 32) but without moderate-to-severe anxiety or depression (PHQ-9 \< 15 and GAD-7 \< 12). Exclusion criteria include cognitive impairments, severe psychiatric diagnoses, and significant health conditions. Participants will complete an online screening questionnaire and a follow-up call to confirm eligibility. After providing informed consent, participants will be randomised using block randomisation to ensure balanced group distribution.

Quantitative data will be collected at baseline, post-intervention, and at a one-month follow-up for the intervention group. Qualitative data will be gathered through post-intervention interviews with 12 participants, using thematic analysis to explore experiences and engagement. Statistical analysis will include two-way repeated measures ANOVAs and exploratory mediation models to evaluate changes in key outcomes.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Aged 18 to 64.
  • Access to a computer or mobile device with internet connectivity.
  • Ability to understand and speak English.
  • IPS score ≥ 32 to confirm severe procrastination.
  • PHQ-9 score < 15 to exclude moderate-to-severe depressive symptoms.
  • GAD-7 score < 12 to exclude moderate-to-severe anxiety symptoms.
Exclusion Criteria
  • Cognitive impairments, significant health conditions or disabilities affecting the ability to provide consent and fully participate.
  • Psychiatric diagnoses requiring specialist care (e.g., schizophrenia, eating disorders, substance misuse). Such participants will be signposted to relevant local services if needed.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in Irrational Procrastination Scale (IPS)From enrolment to one-month follow-up (8 weeks in total).

Irrational Procrastination Scale is a self-report questionnaire measuring procrastination with 9 items on a 5-point Likert scale from 1 (Very Self or Not True of Me) to 5 (Very Often True, or True of Me). The total score is obtained by adding up the scores of each response, with three items reverse-coded. The total score ranges from 9 to 45. IPS has good internal consistency, strong reliability and concurrent validity for use across diverse populations. administered at sign-up, post-intervention, and at one-month follow-up to monitor the effectiveness of the intervention.

Secondary Outcome Measures
NameTimeMethod
Change in General Self-Efficacy Scale (GSE)From enrolment to one-month follow-up (8 weeks in total).

General Self-Efficacy Scale is a self-report questionnaire measuring self-efficacy with 10 items on a 4-point Likert scale from 1 (Not at all true) to 4 (Exactly true), with the total score ranging from 10 to 40. General Self-Efficacy Scale has good internal consistency, strong reliability and concurrent validity for use across different settings and groups. General Self-Efficacy Scale is a secondary measure of this study, administered at sign-up, post-intervention, and at one-month follow-up.

Change in Cantril LadderFrom enrolment to one-month follow-up (8 weeks in total).

Cantril Ladder measures life satisfaction on an 11-point Likert scale from 0 (Worst possible life) to 10 (Best possible life). Cantril Ladder has good internal consistency, strong reliability and concurrent validity for use across different populations. Cantril Ladder is a secondary measure of this study, administered at sign-up, post-intervention, and at one-month follow-up.

Trial Locations

Locations (1)

Overcome

🇬🇧

Arnside, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath